News

December 7, 2007 – The Siemens “Win an MRI" contest has closed and the polls are now open to award a MAGNETOM Essenza ...

Home December 06, 2007
Home
News

December 7, 2007 - Edwards Lifesciences Corp. today has entered into a definitive agreement to sell certain assets related to the Edwards LifeStent peripheral vascular product line to C.R. Bard Inc. for up to $140 million. The transaction is expected to close in January 2008, pending regulatory approvals.

Home December 06, 2007
Home
News

December 7, 2007 - Cardinal Health and HemCon Medical Technologies Inc. this week announced the availability of co ...

Home December 06, 2007
Home
News

December 6, 2007 - The first commercial implant of the Mitroflow Aortic Pericardial Heart Valve in the U.S. was ...

Home December 05, 2007
Home
News

By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - More so than in previous years ...

Home December 05, 2007
Home
News

December 6, 2007 - Boston Scientific Corp. welcomed the recommendation of a FDA advisory panel to approve with ...

Home December 05, 2007
Home
News

By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - At this year’s RSNA more PACS ...

Home December 05, 2007
Home
News

December 6, 2007 – Patients treated with a rotablator drill less risk of perforation than those treated with the excimer ...

Home December 05, 2007
Home
News

December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...

Home December 05, 2007
Home
News

December 5, 2007 - The United Kingdom's Department of Health said today it will begin a new stroke strategy in which ...

Home December 04, 2007
Home
News

December 5, 2007 - Bristol-Myers Squibb will divest its medical imaging division as part of an initiative to maximize ...

Home December 04, 2007
Home
Technology

Starion Instruments' TLS3 Tissue Ligating Shears feature Starion’s proprietary thermal welding technology, focusing ...

Home December 04, 2007
Home
News

December 4, 2007 - Patients treated with Abbott Laboratories Inc.’s experimental drug-coated heart stent had low rates ...

Home December 03, 2007
Home
News

December 4, 2007 - ELA Medical Inc. intiated U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications), which will evaluate therapies and advanced algorithms in optimizing treatment and managing ICD patients.

Home December 03, 2007
Home
News

December 4, 2007 – American College of Cardiology CEO Jack Lewin has urged ACC members this week to let "their members ...

Home December 03, 2007
Home
Subscribe Now